BeStock  
Stocks › Biotechnology › IMCR

Immunocore IMCR

US equityMarket cap rank #2944Biotechnology
$26.41 −$0.22 (-0.83%)
Market closed · Nov 20, 8:10 pm ET · Last extended-hours $26.41 0.00%
Open$26.37
Prev close$26.63
Day range$25.61 – $26.82
Volume546.2K
Market cap$1.36B
P/E (TTM)–
Dividend yield–

Fundamentals

Latest reported quarter: Q3, ended Sep 2026

Revenue$102.22M-1.4% YoY
Operating profit-$13.61M-89.8% YoY
Net profit-$14.22M-7,935.0% YoY
Diluted EPS-$0.28
Free cash flow$17.74M+441.0% YoY
Operating cash flow$20.09M

Revenue, last 8 quarters

$84.1MDec '24$93.9MMar '25$98.0MJun '25$103.7MSep '25$104.5MDec '25$106.7MMar '26$115.9MJun '26$102.2MSep '26

Net profit, last 8 quarters

$-23.8MDec '24$5.0MMar '25$-10.3MJun '25$-177.0KSep '25$-30.1MDec '25$13.0MMar '26$-808.0KJun '26$-14.2MSep '26

Diluted EPS by quarter

-0.47Dec '240.10Mar '25-0.20Jun '250.00Sep '25-0.60Dec '250.25Mar '26-0.02Jun '26-0.28Sep '26

Free cash flow by quarter

$-17.5MDec '24$137.0KMar '25$25.6MJun '25$-5.2MSep '25$-35.5MDec '25$-15.6MMar '26$15.1MJun '26$17.7MSep '26

Annual revenue

$41.0MFY20$36.5MFY21$174.4MFY22$249.4MFY23$310.2MFY24$400.0MFY25

Profitability & balance sheet

Gross margin98.9%
Operating margin-6.8%
Net margin-7.5%
Return on equity-7.9%
Return on assets-2.9%
Return on invested capital-4.0%
Current ratio4.62
Liabilities / assets62.8%
Cash & investments$901.30M
Total debt$433.97M
Net cash (debt)$467.33M

Income statement

Line item 2026 Q3 2026 Q2 2026 Q1 2025 ANNUAL 2025 Q4
Total Revenue as Reported $102.22M $115.93M $106.68M $400.02M $104.48M
Total Operating Revenue $102.22M $115.93M $106.68M $400.02M $104.48M
Cost of Revenue $676,000.00 $1.09M $434,000.00 $5.09M $2.70M
Gross Profit $101.55M $114.84M $106.24M $394.93M $101.78M
Operating Expense $115.16M $117.84M $98.96M $440.28M $121.47M
Selling and Admin Expenses $40.45M $43.89M $37.85M $165.41M $42.65M
Research & Development $74.70M $73.95M $61.11M $274.87M $78.82M
Operating Profit -$13.61M -$3.00M $7.28M -$45.35M -$19.69M
Net Non-Operating Interest Income (Expense) $547,000.00 $520,000.00 $367,000.00 $4.31M $853,000.00
Non-Operating Interest Income $3.61M $3.58M $3.42M $16.48M $3.91M
Non-Operating Interest Expense $2.52M $2.52M $3.05M $12.17M $4.62M
Total Other Finance Costs $543,000.00 $547,000.00 – – –
Other Income (Expense) -$1.01M $1.96M $5.63M $21.94M $3.04M
Gain on Sale of Security -$1.77M -$1.11M $3.85M $2.22M -$1.46M
Other Non-Operating Income (Expenses) $763,000.00 $3.07M $1.78M $19.73M $4.50M
Pretax Profit -$14.07M -$514,000.00 $13.27M -$19.10M -$15.79M
Tax $153,000.00 $294,000.00 $301,000.00 $16.41M $14.27M
Net Profit -$14.22M -$808,000.00 $12.97M -$35.51M -$30.06M
Profit from Continuing Operations -$14.22M -$808,000.00 $12.97M -$35.51M -$30.06M
Net Income to Parent Company -$14.22M -$808,000.00 $12.97M -$35.51M -$30.06M
Net Income to Common Stockholders -$14.22M -$808,000.00 $12.97M -$35.51M -$30.06M
Basic EPS -$0.28 -$0.02 $0.26 -$0.71 -$0.60
Diluted EPS -$0.28 -$0.02 $0.25 -$0.71 -$0.60

Balance sheet

Line item 2026 Q3 2026 Q2 2026 Q1 2025 ANNUAL 2025 Q4
Total Assets $1.13B $1.12B $1.07B $1.07B $1.07B
Total Current Assets $1.06B $1.05B $1.00B $996.74M $996.74M
Cash and Cash Equivalents & Short-Term Investments $901.30M $880.21M $844.90M $864.15M $864.15M
-Cash and Cash Equivalents $512.25M $484.92M $452.68M $467.71M $467.71M
-Short Term Investments $389.05M $395.29M $392.22M $396.44M $396.44M
Receivables $88.03M $95.35M $81.07M $101.12M $101.12M
-Accounts Receivable $88.03M $95.35M $81.07M $73.98M $73.98M
Inventory $7.47M $7.79M $8.25M $6.74M $6.74M
Other Current Assets $63.64M $67.69M $69.59M $6.75M $6.75M
Total Non-Current Assets $68.81M $68.38M $68.29M $70.53M $70.53M
Net PPE $50.33M $49.88M $49.67M $50.25M $50.25M
-Gross PPE $50.33M $49.88M $49.67M $111.05M $111.05M
Other Non-Current Assets $18.48M $18.50M $18.61M $20.28M $20.28M
Total Liabilities $709.53M $699.62M $678.42M $686.24M $686.24M
Total Current Liabilities $229.62M $235.20M $240.11M $246.70M $246.70M
Payables $21.39M $26.32M $30.16M $24.36M $24.36M
-Accounts Payable $21.39M $26.32M $30.16M $24.36M $24.36M
Current Accrued Expenses $193.37M $197.27M $202.16M $203.20M $203.20M
Short-Term Debt and Capital Lease Obligation $1.77M $1.91M $2.00M $2.01M $2.01M
-Current Capital Lease Obligation $1.77M $1.91M $2.00M $2.01M $2.01M
Current Deferred Liabilities $573,000.00 $573,000.00 $572,000.00 $583,000.00 $583,000.00
Total Non-Current Liabilities $479.91M $464.43M $438.31M $439.54M $439.54M
Non-Current Accrued Expenses $41.60M $26.88M – – –
Long Term Debt and Capital Lease Obligation $433.97M $433.05M $433.69M $434.68M $434.68M
-Long Term Debt $394.75M $394.21M $393.66M $393.13M $393.13M
-Long Term Capital Lease Obligation $39.22M $38.85M $40.03M $41.56M $41.56M
Non-Current Deferred Liabilities $4.34M $4.49M $4.62M $4.86M $4.86M
Total Equity $419.71M $419.80M $393.67M $381.03M $381.03M
Stockholders' Equity $419.71M $419.80M $393.67M $381.03M $381.03M
Capital Stock $139,000.00 $138,000.00 $137,000.00 $136,000.00 $136,000.00
-Common Stock $139,000.00 $138,000.00 $137,000.00 $136,000.00 $136,000.00
Additional Paid-In Capital $1.29B $1.27B $1.25B $1.24B $1.24B
Retained Earnings -$833.33M -$819.11M -$818.30M -$831.28M -$831.28M
Gains/Losses Not Affecting Retained Earnings -$33.68M -$34.33M -$35.37M -$28.08M -$28.08M
Other Equity Interests $1,000.00 $1,000.00 $1,000.00 $1,000.00 $1,000.00
-Taxes Receivable – – – $27.14M $27.14M
Prepaid Assets – – – $17.98M $17.98M
-Accumulated Depreciation – – – -$60.80M -$60.80M
Non-Current Deferred Assets – – – $0.00 $0.00

Cash flow

Line item 2026 Q3 2026 Q2 2026 Q1 2025 ANNUAL 2025 Q4
Operating Cash Flow $20.09M $15.93M -$13.78M -$10.71M -$32.66M
Net cash flow from continuing operations $20.09M $15.93M -$13.78M -$10.71M -$32.66M
Net Income from Continuing Operations -$14.22M -$808,000.00 $12.97M -$35.51M -$30.06M
Gain/Loss from Continuing Operations $1.26M $808,000.00 -$3.49M -$6.39M $3.84M
Depreciation & Depletion & Amortization $1.11M $1.03M $948,000.00 $3.27M $834,000.00
Other Non-Cash Items $1.20M $1.16M $1.16M $4.46M $1.20M
Change in Working Capital $21.78M $7.41M -$29.89M -$9.30M -$27.10M
-Change in Receivables $6.75M -$14.62M -$7.93M -$7.34M $1.99M
-Change in Prepaid Assets $3.88M $2.10M -$18.77M -$6.74M -$1.02M
-Change in Payables and Accrued Expense $10.41M $22.20M -$2.33M $13.43M -$20.61M
-Change in Other Current Assets $637,000.00 -$755,000.00 $150,000.00 -$6.18M -$4.71M
-Change in Other Current Liabilities $246,000.00 -$1.36M -$864,000.00 -$2.09M -$2.62M
-Change In Other Working Capital -$144,000.00 -$146,000.00 -$146,000.00 -$387,000.00 -$144,000.00
Net cash flow from investing $4.65M -$786,000.00 $4.22M -$16.34M -$880,000.00
Net Cash Flow from Continuing Investing Activities $4.65M -$786,000.00 $4.22M -$16.34M -$880,000.00
Net PPE Purchase and Sale -$2.35M -$786,000.00 -$1.78M -$4.34M -$2.88M
Net Investment Purchase and Sale $7.00M $0.00 $6.00M -$12.00M $2.00M
Financing Cash Flow $3.76M $16.49M $656,000.00 $12.37M $4.28M
Net Cash Flow from Continuing Financing Activities $3.76M $16.49M $656,000.00 $12.37M $4.28M
Proceeds from Stock Option Exercised $3.76M $16.49M $656,000.00 $12.37M $4.28M
Ending Cash Balance $512.25M $484.92M $452.68M $467.71M $467.71M
Net Change in Cash $28.50M $31.63M -$8.90M -$14.68M -$29.25M
Beginning Cash Balance $484.92M $452.68M $467.71M $455.73M $498.41M
Effect of Exchange Rate Changes -$1.17M $618,000.00 -$6.13M $26.66M -$1.45M
Free Cash Flow $17.74M $15.14M -$15.56M -$15.05M -$35.54M
Deferred Tax – – – $14.79M –
Net Issuance Payments Of Debt – – – $0.00 $0.00
Net Common Stock Issuance – – – $0.00 –

Discussion

No comments yet — be the first to weigh in on IMCR.

Sign in to join the discussion.

Scroll to Top